Linking Pharmacy Revenue Cycle and 340B Program

This guide outlines the critical relationship between the pharmacy revenue cycle and the 340B Drug Pricing Program within healthcare organizations. It explains how financial sustainability is increasingly important, as medications represent a significant expense for hospitals and health systems. The document details the importance of optimizing medication-related financial processes, emphasizing that aligning the pharmacy revenue cycle with the 340B program can enhance revenue capture and ensure compliance, ultimately improving financial performance and patient care for underserved populations. The guide describes the pharmacy revenue cycle's role in managing medication billing, reimbursement, and financial management, highlighting the need for effective management to improve cash flow and reduce costs. It also discusses the challenges of maintaining compliance with the 340B program and the importance of capturing complete charges for medications to maximize savings. Strategies for healthcare leaders include fostering cross-departmental collaboration, ongoing education, and investing in integrated technology solutions to achieve operational efficiency and compliance.